Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
GRP78/BiP has recently emerged as a novel biomarker for aggressive prostate cancer. Here, we report that homozygous deletion of Grp78 specifically in mouse prostate epithelium suppresses prostate tumorigenesis without affecting postnatal prostate development and growth. Mouse prostates with double conditional knockout of Grp78 and Pten exhibit normal histology and cytology, in contrast to the invasive adenocarcinoma in mouse prostates with Pten inactivation. AKT activation in Pten null prostate epithelium is inhibited by Grp78 homozygous deletion, corresponding with suppression of AKT phosphorylation by GRP78 knockdown in prostate cancer cell line. Thus, inactivation of GRP78 may represent a previously undescribed approach to stop prostate cancer and potentially other cancers resulting from the loss of PTEN tumor suppression and/or activation of the oncogenic AKT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, suppression of BiP signaling by KP1339 (also known as IT‐139) or HA15 in glioblastoma, bladder or breast cancer cell lines has been shown to enhance the response to anti‐cancer therapy [194, 195].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [194]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 1×
“Pten homozygous deletion in mice causes early embryonic death, and Pten / mice exhibit hyperplastic-dysplastic changes in multiple organs, including PIN in mouse prostate but no progression to adenocarcinoma (13).”
BackgroundWang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109 · cited 7×
“transgene and f Pten allele on C57BL/6xDBA2/129 background was described previously (15).”
BackgroundResultSelf-citationTenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034 · cited 1×
“If so, what is the underlying mechanism? One of the most common genes involved in prostate cancer is Pten, a nonredundant phosphatase gene frequently deleted or mutated in human cancers (11).”
BackgroundThe Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921 · cited 1×
“As a result, phosphorylation of a wide range of downstream signaling molecules leads to enhanced cell growth and survival (12).”
BackgroundGRP78 Induction in Cancer: Therapeutic and Prognostic Implications
Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0325 · Cited by 856 · cited 3×
“GRP78 is highly induced in a wide range of tumors through intrinsic factors such as altered glucose metabolism of cancer cells, compounded by extrinsic factors such as glucose deprivation, hypoxia, and acidosis in the microenvironment of poorly-perfused solid tumor (7).”
BackgroundER chaperones in mammalian development and human diseases
Ni, M., & Lee, A. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.045 · Cited by 735 · cited 1×
“As a major endoplasmic reticulum (ER) chaperone, GRP78 facilitates protein folding and assembly, protein quality control, ER-associated protein degradation, Ca2 binding, and regulation of transmembrane ER stress inducers (4, 5).”
BackgroundAging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation
Chambers, S. M., Shaw, C. A., Gatza, C., Fisk, C. J., Donehower, L. A., & Goodell, M. A. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050201 · Cited by 731 · cited 1×
“It is also tempting to speculate that GRP78 may have a role in cancer stem cells, because it is required for survival of embryonic stem cell precursors and is among a set of select genes expressed in hematopoietic stem cells (6, 30).”
BackgroundReddy, R. K., Mao, C., Baumeister, P., Austin, R. C., Kaufman, R. J., & Lee, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212328200 · Cited by 695 · cited 1×
“In addition to maintenance of ER homeostasis through protein quality control and serving as an ER Ca2 binding protein, GRP78 with antiapoptotic properties is known to protect cancer cells against immune surveillance (25), and directly interacts with and inhibits caspase-7 (26).”
BackgroundSelf-citationStress Induction of GRP78/BiP and Its Role in Cancer
Li, J., & Lee, A. (2006) · Current Molecular Medicine · doi:10.2174/156652406775574523 · Cited by 599
The ER function BiP is a master regulator of ER function.
Hendershot, L. M. (2004) · PubMed · Cited by 542
Research works printed but not linked: 1
- Fu et al. PNAS ͉ December 9, 2008 ͉ vol. 105 ͉ no. 49 ͉ 19449 MEDICAL SCIENCES
Cited by
Items 101–180 of 180
Lin, Y., Shen, J., Yoo, E., Liu, R., Yen, H.-Y., Mehta, A., Rajaei, A., Yang, W., Mhawech-Fauceglia, P. Y., DeMayo, F. J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.4 · Cited by 37
Lin, C., Chen, W.-H., Liao, C., Chen, I., Chiu, C., Wang, H., Yen, T., Lee, L., Chang, J. T., & Cheng, A. (2009) · Head & Neck · doi:10.1002/hed.21287 · Cited by 37
“GRP78 was found to confer cancer progression and survival advantage through PTEN and Akt pathway in cancer cells.(32,33) GRP78 can also be a cell membrane protein which regulates proliferation and migration of cancer cells by oncogenic Cripto signaling via mitogen-activated protein kinase/phosphatidylinositol 3-kinase…”
BackgroundYe, R., Mareninova, O. A., Barrón, E., Wang, M., Hinton, D. R., Pandol, S. J., & Lee, A. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100368 · Cited by 40
Lee, A. S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412246122 · Cited by 49
GRP78 Mediates Cell Growth and Invasiveness in Endometrial Cancer
Calì, G., Insabato, L., Conza, D., Bifulco, G., Parrillo, L., Mirra, P., Fiory, F., Miele, C., Raciti, G. A., Jeso, B. D., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24578 · Cited by 34
“Moreover, knockout of GRP78 in prostate epithelium has been reported to inhibit prostate cancer formation in mice (Fu et al., 2008).”
BackgroundEndoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis
Rangel, D. F., Dubeau, L., Park, R., Chan, P., Ha, D. P., Pulido, M. A., Mullen, D. J., Vorobyova, I., Zhou, B., Borok, Z., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01791-9 · Cited by 38
“To examine the role of GRP78 in mutant Kras-driven LUAD, we crossed the Kras mice with floxed Grp78 (Grp78) mice [22].”
BackgroundMethodStressed Out - Therapeutic Implications of ER Stress Related Cancer Research
Riha, R., Gupta-Saraf, P., Bhanja, P., Badkul, S., & Saha, S. (2017) · Oncomedicine · doi:10.7150/oncm.22477 · Cited by 34
“GRP78 has also been shown to play a critical role in tumorigenesis of prostate adenocarcinoma in mice with PTEN tumor suppressor gene deletion [28].”
Kim, J. H., Lee, E., Friedline, R. H., Suk, S., Jung, D. Y., Dağdeviren, S., Hu, X., Inashima, K., Noh, H. L., Kwon, J. Y., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701017r · Cited by 38
“Floxed-GRP78 (GRP78) mice were generated as previously described (17).”
MethodROS-independent Nrf2 activation in prostate cancer
Bellezza, I., Scarpelli, P. T., Pizzo, S. V., Grottelli, S., Costanzi, E., & Minelli, A. (2017) · Oncotarget · doi:10.18632/oncotarget.18724 · Cited by 36
Chen, J., Chen, K., Wang, L., Luo, J., Zheng, Q., & He, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04972-w · Cited by 42
Ha, D. P., Huang, B., Wang, H., Rangel, D. F., Krieken, R. V., Liu, Z., Samanta, S., Neamati, N., & Lee, A. S. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100837 · Cited by 35
Chang, Y.-W., Chen, H.-A., Tseng, C.-F., Hong, C., Ma, J.-T., Hung, M., Wu, C., Huang, M., & Su, J.-L. (2014) · Oncotarget · doi:10.18632/oncotarget.2510 · Cited by 36
“Interestingly, knockdown of HSPA5 blocks downstream PI3K/AKT signaling and has been reported to decrease prostate and leukemia tumorigenesis [13, 37].”
BackgroundER stress induces epithelial differentiation in the mouse oesophagus
Rosekrans, S. L., Heijmans, J., Büller, N. V. J. A., Westerlund, J., Lee, A. S., Muncan, V., & van den Brink, G. R. (2014) · Gut · doi:10.1136/gutjnl-2013-306347 · Cited by 34
Endoplasmic Reticulum Stress in Endometrial Cancer
Ulianich, L., & Insabato, L. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00055 · Cited by 36
“GRP78 expression has been reported to be increased in a number of human cancers, including breast (19, 20), lung (21, 22), prostate (23, 24), ovarian (25), gastric (26), hepatocellular (27, 28), esophageal (29), renal (30), endometrial (31, 32), melanoma (33), glioma (34), and fibrosarcoma (35) (Table 1).”
BackgroundWinder, T. L., Bohanes, P. O., Zhang, W., Yang, D., Power, D. G., Ning, Y., Gerger, A., Wilson, P. M., Tang, L. H., Shah, M. A., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq771 · Cited by 31
“[37] revealed that Akt phosphorylation—the major antiapoptotic and pro-proliferative signaling mechanism—is inhibited by knockdown of GRP78 in prostate cancer [37].”
BackgroundXie, J., Tao, Z., Zhao, J., Li, T., Wu, Z., Zhang, J.-F., Zhang, J., & Hu, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.002 · Cited by 30
The Par-4-GRP78 TRAIL, more twists and turns
Lee, A. S. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.22.10140 · Cited by 30
Sriratanasak, N., Chunhacha, P., Zin, Z., & Chanvorachote, P. (2022) · Biomedicines · doi:10.3390/biomedicines10112703 · Cited by 31
Novel interactions of GRP78: UPR and estrogen responses in the brain
Ávila-Rodriguez, M., Cabezas, R., Torrente, D., González, J., Morales, L., Alvarez, L., Capani, F., & Barreto, G. E. (2013) · Cell Biology International · doi:10.1002/cbin.10058 · Cited by 30
Modelling the effect of GRP78 on anti-oestrogen sensitivity and resistance in breast cancer
Parmar, J. H., Cook, K. L., Shajahan‐Haq, A. N., Clarke, P. A. G., Tavassoly, I., Clarke, R. C., Tyson, J. J., & Baumann, W. T. (2013) · Interface Focus · doi:10.1098/rsfs.2013.0012 · Cited by 31
“GRP78 knockdown is also known to induce apoptosis by blocking AKT activation in colon, PTEN-null leukaemia and prostate cancer cell lines [88,96,97].”
BackgroundSun, S., Kiang, K. M. Y., Ho, A. S.-W., Lee, D., Poon, M.-W., Xu, F., Pu, J. K.-S., Kan, A., Lee, N. P. Y., Liu, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18026 · Cited by 27
The Unfolded Protein Response at the Tumor-Immune Interface
Zanetti, M., Su, X., Dosset, M., & Carter, H. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.823157 · Cited by 27
“mice, the conditional homozygous knockout of Grp78 in the prostate of mice with Pten inactivation protects against cancer growth (41).”
BackgroundGuo, W., Wang, M., Yang, Z., Liu, D., Ma, B., Zhao, Y., Chen, Y., & Hu, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115792 · Cited by 31
GRP78 regulates sensitivity of human colorectal cancer cells to DNA targeting agents
Mhaidat, N. M., Alzoubi, K. H., Khabour, O. F., BaniHani, M. N., Al-Balas, Q. A., & Swaidan, S. (2014) · Cytotechnology · doi:10.1007/s10616-014-9799-8 · Cited by 26
Chen, W., Ha, D. P., Kanel, G. C., & Lee, A. S. (2014) · Neoplasia · doi:10.1016/j.neo.2014.07.005 · Cited by 25
“Histology and Immunostaining Mouse liver tissues were fixed in 10% zinc formalin, embedded in paraffin, sectioned at 4 μm, and subjected to H&E staining and immunostaining as described [22].”
MethodIjuin, T., Hatano, N., Hosooka, T., & Takenawa, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.009 · Cited by 27
Cell‐extrinsic effects of the tumor unfolded protein response on myeloid cells and T cells
Zanetti, M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12103 · Cited by 22
Chen, Y., Chen, J., Zhang, C., Yang, S., Zhang, X., Liu, Y., & Su, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201901474rr · Cited by 23
“In cancer cell lines and cancer mouse models, knockdown of GRP78 suppressed the conversion of phosphatidylinositol 4,5bisphosphate to PIP3 at the cell surface and reducedAKT phosphorylation (37, 38).”
BackgroundPrognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma
Ogawa, H., Kaira, K., Takahashi, K., Shimizu, A., Altan, B., Yoshinari, D., Asao, T., & Oyama, T. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170062 · Cited by 22
“Fu et al. have shown that Akt phosphorylation, known as the major antiapoptotic and pro-proliferative signaling, is inhibited by the knockdown of BiP/GRP78, suggesting that the silencing of BiP/GRP78 expression is linked to the loss of PTEN tumor suppression and oncogenic Akt activation [19].”
Schneider, M., Winkler, K., Kell, R., Pfaffl, M. W., Atkinson, M. J., & Moertl, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.842418 · Cited by 23
“Accordingly, a knockout of GRP78 suppressed Akt activation in vivo (5).”
BackgroundIha, K., Sato, A., Tsai, H.-Y., Sonoda, H., Watabe, S., Yoshimura, T., Lin, M., & Ito, E. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44120419 · Cited by 28
Identification of ΔNp63α Protein Interactions by Mass Spectrometry
Amoresano, A., Costanzo, A. D., Leo, G., Cunto, F. D., Mantia, G. L., Guerrini, L., & Calabrò, V. (2010) · Journal of Proteome Research · doi:10.1021/pr9011156 · Cited by 21
Kumandan, S., Mahadevan, N. R., Chiu, K., DeLaney, A. A., & Zanetti, M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.014 · Cited by 22
“UPR signaling is upregulated in tumors of several histological subtypes, and has been shown to be crucial tumor growth, adaptation, and resistance to chemotherapy [19; 20; 21; 22].”
BackgroundInfluentialProtein quality control in the endoplasmic reticulum
Koenig, P.-A., & Ploegh, H. L. (2014) · F1000Prime Reports · doi:10.12703/p6-49 · Cited by 24
“Tissue-specific knockouts in adipocytes, prostate epithelial cells, or Purkinje cells produce severe cellular defects in the affected tissues [30-46].”
BackgroundYang, C., Zhang, Z., Zou, Y., Gao, G., Liu, L., Xu, H., & Liu, F. (2020) · Histology and histopathology · doi:10.14670/hh-18-185 · Cited by 21
Thakur, G., Sathe, G. J., Kundu, I., Biswas, B., Gautam, P., Alkahtani, S. H., Idicula‐Thomas, S., Sirdeshmukh, R., Kishore, U., & Madan, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600660 · Cited by 19
“Prostate tumorigenesis was potently arrested in bi-allelic conditional knockout mice for both GRP78 and PTEN (57).”
BackgroundLee, A. S., Brandhorst, S., Rangel, D. F., Navarrete, G., Cohen, P., Longo, V. D., Chen, J., Groshen, S. G., Morgan, T. E., & Dubeau, L. (2017) · Scientific Reports · doi:10.1038/srep40919 · Cited by 18
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer
Liang, L., Bi, W., Chen, W., Lin, Y., & Tian, Y. (2018) · Lasers in Medical Science · doi:10.1007/s10103-017-2331-6 · Cited by 15
Heat Shock Proteins: Potential Modulators and Candidate Biomarkers of Peripartum Cardiomyopathy
Chakafana, G., Spracklen, T. F., Kamuli, S., Zininga, T., Shonhai, A., Ntusi, N., & Sliwa, K. S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.633013 · Cited by 15
Direito, I., Fardilha, M., & Helguero, L. A. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy182 · Cited by 17
Endoplasmic reticulum stress, unfolded protein response and development of colon adenocarcinoma
Piton, N., Wason, J. M. S., Colasse, É., Cornic, M., Lemoine, F., Pessot, F. L., Marguet, F., & Sabourin, J. (2016) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-1961-6 · Cited by 14
Baudi, I., Isogawa, M., Moalli, F., Onishi, M., Kawashima, K., Ishida, Y., Tateno, C., Sato, Y., Harashima, H., Ito, H., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009228 · Cited by 15
“21 prostate tumorigenesis [47], and knockdown of GRP78 sensitizes various cancer cells to 441 chemotoxic, anti-hormonal, DNA damaging, and anti-angiogenesis agents [48].”
BackgroundDifferential requirement of GRP94 and GRP78 in mammary gland development
Zhu, G., Wang, M., Spike, B. T., Gray, P. C., Shen, J., Lee, S., Chen, S., & Lee, A. S. (2014) · Scientific Reports · doi:10.1038/srep05390 · Cited by 13
Kaira, K., Toyoda, M., Shimizu, A., Imai, H., Sakakura, K., Nikkuni, O., SUZUKI, M., IIJIMA, M., Asao, T., & Chikamatsu, K. (2016) · Neoplasma · doi:10.4149/319_151002n513 · Cited by 13
“In an experimental study, it was reported that silencing of GRP78/BiP expression may be related to the loss of PTEN tumor suppression and oncogenic AKT activation [17].”
BackgroundAyub, A., Hasan, M. K., Mahmud, Z., Hossain, M. S., & Kabir, Y. (2024) · Medical Oncology · doi:10.1007/s12032-024-02417-2 · Cited by 16
Luo, B., Tseng, C.-C., Adams, G. B., & Lee, A. S. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0181 · Cited by 12
“Deficiency of another major ER chaperone, GRP78, impairs the activation of PI3K-AKT pathway in vitro as well as in PTEN-null prostate cancer and leukemia mouse models [36,52].”
Oncostatin M up-regulates the ER chaperone Grp78/BiP in liver cells
Vollmer, S., Haan, C., & Behrmann, I. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.015 · Cited by 13
“It is known that Grp78 is widely expressed in cancer cells and seems to favor tumor development, proliferation and survival of cancer cells and tumor angiogenesis [17,41,42].”
Background[Lunar phases and incidence of spontaneous deliveries. Our experience].
Periti, E., & Biagiotti, R. (1994) · PubMed · Cited by 19
Ha, D. P., Shin, W.-J., Liu, Z., Doche, M. E., Lau, R., Leli, N. M., Conn, C. S., Russo, M., Lorenzato, A., Koumenis, C., et al. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01297-3 · Cited by 12
“Immunostaining of paraffin-embedded tumor tissue sections was performed as described previously [74].”
MethodAnspach, L., Tsaryk, R., Seidmann, L., Unger, R. E., Jayasinghe, C., Simiantonaki, N., Kirkpatrick, C. J., & Pröls, F. (2020) · The Journal of Pathology · doi:10.1002/path.5423 · Cited by 11
Chen, W., & Lee, A. S. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-385114-7.00013-1 · Cited by 13
Zhou, X., Xing, X., Zhang, S., Liu, L., Wang, C., Li, L., Ji, Q., & Liu, H. (2016) · Oncology Reports · doi:10.3892/or.2016.5097 · Cited by 10
“This result was consistent with the finding that deletion of GRP78 can suppress the AKT activation and tumorigenesis (24).”
BackgroundResultLu, T., Yang, W., Wang, Z., Hu, Z., Zeng, X., Yang, C., WANG, Y., Zhang, Y., Li, F., Liu, Z., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2737 · Cited by 10
Jia, L., Ji, S., Maillet, J., & Zhang, X. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22867 · Cited by 13
Gkouveris, I., Nikitakis, N. G., Aseervatham, J., & Ogbureke, K. U. E. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4484 · Cited by 14
“Previous studies have suggested that GRP78 promotes tumor progression (44,45), and increased GRP78 expression has been correlated with reduced patient survival and shorter recurrence time in esophageal squamous cell carcinoma, prostate and breast cancer (41,46,47).”
Shen, J., Yao, L., Lin, Y. G., DeMayo, F. J., Lydon, J. P., Dubeau, L., & Lee, A. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7450 · Cited by 10
“Immunostaining on paraffin-embedded or frozen tissue sections was performed as described previously [13, 42].”
Limso, C., Ngo, J. M., Nguyen, P., Leal, S., Husain, A., Sahoo, D., Ghosh, P., & Bhandari, D. (2019) · FEBS Letters · doi:10.1002/1873-3468.13685 · Cited by 9
Evaluation of Docetaxel-Sensitive and Docetaxel-Resistant Proteomes in PC-3 Cells
Zu, S., Ma, W., Xiao, P., Cui, Y., Ma, T., Zhou, C.-W., & Zhang, H. (2015) · Urologia Internationalis · doi:10.1159/000351263 · Cited by 9
Endoplasmic reticulum protein ERp46 in prostate adenocarcinoma
Duivenvoorden, W., Hopmans, S., Austin, R. C., & Pinthus, J. H. (2017) · Oncology Letters · doi:10.3892/ol.2017.5908 · Cited by 9
“The ability to activate the unfolded protein response has been linked to prostate tumorigenesis and cancer progression, as prostate‑specific deletion of GRP78 in phosphatase and tensin homolog‑deficient mice has been demonstrated to inhibit prostate tumorigenesis (17).”
Gkouveris, I., Nikitakis, N. G., Aseervatham, J., & Ogbureke, K. U. E. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4590 · Cited by 12
“This speculation is based on the results of previous studies, which provide evidence indicating that GRP78 promotes tumor progression (47,48), and increased GRP78 expression is correlated with shorter recurrence time and poor survival of patients with prostate and breast cancers (49‑51).”
Wang, F., Yin, J., Wang, X., Zhang, H., Song, Y., Zhang, X., & Wang, T. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.175040 · Cited by 5
Ni, B., Shi, L., Zhao, L., Gao, L., Luo, L., Zhang, J., Xie, X., Zhu, Y., Yang, W. Y., Min, S., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.109973 · Cited by 3
Activation of PD-1/PD-L1 immune checkpoint by Zika virus
Wang, C., Xie, Y., Li, W., Ong, C. P., Ding, H., Yuan, S., Cheng, G., Jin, D., & Ye, Z. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013457 · Cited by 3
Wang, W., Liu, J., Kha, N. H. A., Shen, W., Chen, C., Chen, S.-C., Liao, P.-C., Huang, C., & Kuo, W. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.107240 · Cited by 4
“3A) , which could be associated with facilitating cell adaptation to stress for survival through the PI3K/Akt pathway [20, 21].”
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications
Singh, N., & Heemers, H. V. (2023) · Endocrine Related Cancer · doi:10.1530/erc-23-0011 · Cited by 4
Barber, D. L. (2012) · Blood · doi:10.1182/blood-2011-11-382614 · Cited by 2
Biswas, A., Singh, G., Arya, V., Lakhotia, S. C., & Sinha, D. (2026) · Journal of Cell Science · doi:10.1242/jcs.264402 · Cited by 1
Engineering Antibody Fragment with the Quantum Dot in Cancer Cell Imaging and Diagnosis
Liu, L., & Xu, W. (2012) · Engineering · doi:10.4236/eng.2012.410b033 · Cited by 1
“Especially, In double knock-out PTEN (a tumor suppressor cells) and GRP78, prostate tumorigenesis was[6] blocked and prostate cancer development were completely halted, indicating GRP78 being a crucial gene in prostate cancer growth, cell invasion and angiogenesis.”
BackgroundOutside the Endoplasmic Reticulum: Non-Canonical GRP78 Signaling
Cook, K. L. (2019) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-05067-2_9 · Cited by 1
Evaluating the Therapeutic Potential of mTOR Inhibitors Using Mouse Genetics
Li, H., Cotton, J. L., & Guertin, D. A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_21 · Cited by 1
Identification of low-abundance proteins in the royal jelly using the Osborne classification method
Pei, P., Guo, W., Qi, M., Jiang, J., Feng, S., Luo, S., & Chen, L. (2024) · Journal of Proteomics · doi:10.1016/j.jprot.2024.105266 · Cited by 1
Nakamura, T., & Lipton, S. A. (2011) · Wiley eBooks · doi:10.1002/9781118063903.ch2
Leading causes of castration-resistant prostate cancer
Lu, M., Lu, H., & Kong, Q.-Z. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1007957 · Cited by 1
“In vitro and in vivo, suppression of AKT activity and mTOR with their specific inhibitors can lead to anticancer effect [18,75,76].”
BackgroundCell-Nonautonomous ER Stress-Mediated Dysregulation of Immunity by Cancer Cells
Rodvold, J. J., Mahadevan, N. R., & Zanetti, M. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_18
Bachelder, R. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812351-5.00006-4
Endoplasmic reticulum stress protein GRP78 for ketamine’s antidepressant effectsPreprint
Cui, W., Shen, C., Xiong, W., & Mei, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.22.639685
Ha, D. P., Shin, W.-J., Liu, Z., Doche, M. E., Lau, R., Leli, N. M., Conn, C. S., Russo, M., Lorenzato, A., Koumenis, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26952409
Ha, D. P., Shin, W.-J., Liu, Z., Doche, M. E., Lau, R., Leli, N. M., Conn, C. S., Russo, M., Lorenzato, A., Koumenis, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26952406
Thapa, P., Subedi, P., Demissie, R., Lee, H., & Johnson, J. J. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118252
Metadata
- Authors
- Fu, Y., Wey, S., Wang, M., Ye, R., Liao, C.-P., Roy-Burman, P., & Lee, A. S.
- Affiliations
- University of Southern California (US)
- Departments of aBiochemistry and Molecular Biology and
- Pathology, University of Southern California Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA 90089-9176
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-12-09
- Volume
- 105
- Issue
- 49
- Pages
- 19444-19449
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2614780
- OpenAlex
- W2008683065
- Cited by
- 180
- References
- 31
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 5 · 2019: 5 · 2018: 10 · 2017: 12 · 2016: 10 · 2015: 9 · 2014: 20 · 2013: 14 · 2012: 16
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Southern California
- University of California, Los Angeles
- National Cancer Institute (CA 113392, R01CA027607, CA27607, R01CA113392)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- GRP78, PTEN, prostate cancer, prostate tumorigenesis, Akt activation, Akt phosphorylation, conditional knockout, prostate epithelium, ER chaperones, tumor suppressor loss, invasive adenocarcinoma, mouse model
- MeSH terms
- Endoplasmic Reticulum Chaperone BiP, Adenocarcinoma, Animals, Epithelium, Fluorescent Antibody Technique, Heat-Shock Proteins, Homozygote, Male, Mice, Inbred C57BL, Prostate, Prostatic Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Mice, Knockout, Molecular Chaperones, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.